Neurocrine Biosciences (NBIX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Neurocrine Biosciences, as the data feed reports them.

Analysts' mean target, 28 analysts
$208.54
25.7% above the price

The 28 analysts reported by the data feed have a mean price target for Neurocrine Biosciences of $208.54, 25.7% above the $165.92 price (range $150.00–$253.00). 7.58% of the float was sold short as of Oct 30, 2026. Institutions hold 104.9% of the shares and insiders 1.1%. Source: Yahoo Finance, read Nov 18, 2026.

Key facts

Analysts' mean target
$208.54+25.7% vs price
Analysts
28
Short interest
7.58%of float, Oct 30, 2026
Short ratio
4.53 days
Institutions
104.9%
Insiders
1.08%
Beta
0.33

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

28 analysts covering Neurocrine Biosciences, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $165.92.

Analysts' price targets for Neurocrine Biosciences
Mean price target$208.5425.7% above the price (+25.7%)
Median price target$215.0029.6% above the price (+29.6%)
Highest target$253.0052.5% above the price (+52.5%)
Lowest target$150.009.6% below the price (−9.6%)
Analysts with a target28

Ratings this month · 28 analysts

Strong buy 4(14%)Buy 20(71%)Hold 4(14%)
Analysts' ratings of Neurocrine Biosciences this month, by rating
RatingAnalystsShare
Strong buy414%
Buy2071%
Hold414%
Sell00%
Strong sell00%

The feed averages these to 1.43 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Neurocrine Biosciences

Ownership of Neurocrine Biosciences
Held by institutions104.9%1,138 institutions; percent of shares outstanding
Held by institutions, of the float106.1%
Held by insiders1.08%percent of shares outstanding
Shares outstanding101.22M
Float99.9Mshares available to trade
Insiders' net purchases, six months+32.34K38 purchases (444.25K shares), 18 sales (411.9K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Neurocrine Biosciences
Shares short5.9Mas of Oct 30, 2026
Percent of float7.58%shares short ÷ float
Percent of shares outstanding5.83%shares short ÷ shares outstanding
Short ratio (days to cover)4.53shares short ÷ average daily volume

Neurocrine Biosciences short interest from FINRA, with its history

Trading figures

Trading figures for Neurocrine Biosciences
Beta0.33movement against the market; 1 moves with it
52-week high$186.12
52-week low$122.14
Average volume, 3 months1.31Mshares a day
Average volume, 10 days1.72Mshares a day

Dates to know

Upcoming and recent dates for Neurocrine Biosciences
Ex-dividend dateDec 29, 1995as the feed lists it

Questions and answers

What is the analysts' price target for Neurocrine Biosciences (NBIX)?

As reported by the data feed, the mean price target of the 28 analysts covering Neurocrine Biosciences is $208.54, 25.7% above the latest price of $165.92. The highest target is $253.00 and the lowest $150.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Neurocrine Biosciences stock?

Of the 28 ratings the data feed reports for the current month, 4 are strong buy, 20 buy, 4 hold, 0 sell and 0 strong sell.

How many Neurocrine Biosciences shares are sold short?

As reported by the data feed, 5.9M shares were sold short, 7.58% of the float as of Oct 30, 2026. At the average daily volume that is 4.53 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Neurocrine Biosciences stock?

As reported by the data feed, institutions hold 104.9% of the shares (1,138 institutions) and insiders 1.1%. There are 101.22M shares outstanding, of which 99.9M are in the float.

How much does Neurocrine Biosciences stock move with the market?

Its beta, as reported by the data feed, is 0.33: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $122.14 and $186.12.

Cite this page

Funkfolio, “Neurocrine Biosciences (NBIX) statistics and analyst targets”, data as of 18 November 2026. https://funkfolio.com/stock/NBIX/statistics

Underlying data: Yahoo Finance.